Testing effectiveness (Phase 2)Study completedNCT02690181
What this trial is testing
Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.
Who this might be right for
Bacterial Infection Due to Streptococcus, Group BStreptococcus Agalactiae
GlaxoSmithKline 80